Mizuho Maintains Neutral on Amgen, Raises Price Target to $303

Benzinga Newsdesk www.benzinga.com Positive 61.0%

Neg 0% Neu 0% Pos 61%

Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $295 to $303.

Comments

No comments yet. Be the first!